Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage – the MUSFIH study

A longitudinal study was carried out in 255 children from 10 centres in nine developing countries over 5 years to assess the musculoskeletal outcome of children on episodic factor replacement. Outcome was documented by assessment of the annual joint bleeding rate (AJBR), WFH clinical and Pettersson radiological joint scores as well as the FISH score for activities. Of the 203 patients for whom data was available at the end of 5 years, 164 who had received only episodic treatment are included in this report.

[1]  H. Elmahmoudi,et al.  Low dose prophylaxis in Tunisian children with haemophilia , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  T. Dutta,et al.  A randomized study of very low‐dose factor VIII prophylaxis in severe haemophilia – A success story from a resource limited country , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  Adrienne Lee,et al.  Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[4]  A. Srivastava.  Inflammation is key to hemophilic arthropathy. , 2015, Blood.

[5]  R. Ljung,et al.  Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. , 2013, Blood.

[6]  R. Wu,et al.  Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  J. Stockman.  Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia , 2009 .

[8]  A. Viswabandya,et al.  Psychometric analysis of the Functional Independence Score in Haemophilia (FISH) , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  J. Maahs,et al.  Practice patterns in haemophilia A therapy – global progress towards optimal care , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  D. Grobbee,et al.  Prophylactic versus on‐demand treatment strategies for severe haemophilia: a comparison of costs and long‐term outcome , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  D. Grobbee,et al.  Association between joint bleeds and Pettersson scores in severe haemophilia. , 2002, Acta radiologica.

[12]  A. Srivastava.  Delivery of haemophilia care in the developing world , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  M. Chandy,et al.  Management of haemophilia in the developing world , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[14]  H. Pettersson,et al.  A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs , 1994, Journal of internal medicine.

[15]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[16]  H. Pettersson,et al.  Diagnostic Imaging in Hemophilia , 1985, Springer London.

[17]  Emrys D. Jones.  The Developing World , 1963, Nature.